Key facts
- This page summarizes David A. Berry's Form 4 filing for Omega Therapeutics, Inc. (OMGAQ).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Aug 2021, 17:15.
David A. Berry - 03 Aug 2021 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)
- Reporting relationship
- Director
- Issuer ticker
- OMGAQ
- Reported as of
- 03 Aug 2021
- Net transaction value
- +$902,394
- SEC form
- 4
- Accepted by SEC
- 03 Aug 2021, 17:15:34 UTC
- Prior SEC filing
- 29 Jul 2021
- Next SEC filing
- 22 Oct 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Barbara Chan as Attorney-in-fact for David A. Berry, M.D., Ph.D.
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David A. Berry filed Form 4 for Omega Therapeutics, Inc. (OMGAQ) on 03 Aug 2021.
Change
- Previous filing in this sequence was filed on 29 Jul 2021.
- Current net transaction value: +$902,394.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OMGA
transaction
Common Stock
Purchase
- Transaction value
- $902,394
- Shares
- +53,082
- Change %
- Price
- $17.00
- Shares after
- 53,082
- Date
- 03 Aug 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.